logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Dingdang Health (09886.HK) spent 182,400 Hong Kong dollars to repurchase 200,000 shares on July 16th.

date
16/07/2026
Smart Finance APP News, Dingdang Health (09886.HK) announced that on July 16, 2026, the company spent HK$182,400 to repurchase 200,000 shares at a repurchase price of HK$0.90 to HK$0.92 per share.
Latest
1 m ago
Blessing Life Services (03686.HK) issues a profit warning, expecting a significant year-on-year decline in performance in the first half of 2026.
1 m ago
The Agus research raised the target stock price of Asme from $1700 to $2100.
3 m ago
TSMC's stock price fell by 5% in pre-market trading, closing at $398 per share.
3 m ago
New stock news | Yino Pharmaceuticals submitted its application to the Hong Kong Stock Exchange for the third time. The cumulative loss during the reporting period was approximately 1.66 billion yuan.
5 m ago
Eternal Trust and Sincerity (688244.SH) granted 1.44 million restricted stocks to 20 incentive recipients.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.